KuJiangsu Jingye Pharmaceutical Co., Ltd., tinodada kuva shamwari yakavimbika mugadziriro yemishonga yepasi rose. Semugadziri akasarudzika wezvigadzirwa zvemishonga uye zvepakati, tinonzwisisa basa rakakosha iroGlybenzcyclamide Pakatitamba mukuvandudza nekugadzirwa kwezvinodhaka-kunyanya mukurapwa kwechirwere cheshuga chechipiri.
Hatingogadziri makemikari. Isu tinoendesa kuvimbika, mhando, uye runyararo rwepfungwa kumakambani emishonga pasi rese.
Nei Yedu Glybenzcyclamide Yepakati Inomira Kunze
Glybenzcyclamide Intermediates makomisheni akakosha mukugadzirwa kwe sulfonylurea-class anti-diabetic drugs, kusanganisira Glibenclamide. Hunhu hwepakati idzi hunokanganisa zvakananga kushanda uye kuchengetedzeka kwechigadzirwa chekupedzisira chemushonga.
KuJiangsu Jingye Pharmaceutical, yedu inoshamisira yepakati-4-(2-aminoethyl)benzenesulfonamide-inogadzirwa pasi pemitemo yakasimba yekudzora mhando. Iyo inoenderana neanotevera zviyero:
Kuchena ≥99%, yakasimbiswa nehunyanzvi hwekuongorora (HPLC, GC, NMR)
Kugadzikana kwakanyanya uye kuenderana, kunyangwe pamabheti makuru ekugadzira
Yakazara tsigiro yekutonga, kusanganisira COA, MSDS, uye gadzira data
Flexible supply yeR&D, mutyairi, uye zvekutengesa-chiyero zvinodiwa
Nekusarudza yedu Glybenzcyclamide Intermediates, vatengi vedu vanobatsirwa kubva kune yakapfava synthesis, kushoma kukundikana, uye hwaro hwakasimba hwekutonga.
Innovation iri muDNA Yedu
Nzvimbo yedu yakashongedzerwa nekucheka-kumucheto zviridzwa uye inoshandirwa neyakadzidziswa zvakanyanya tekinoroji timu. Isu tinoramba tichiwedzera maitiro edu kuti tive nechokwadi chekuti vepakati vedu vanosangana nekuchinja kuri kudiwa kweindasitiri yemishonga.
Hatigumiri pakuzadzisa tarisiro — tinozvipfuura. Yedu-mu-imba R&D inotitendera kuti tipe tsika synthesis uye zano rekugadzira kune vatengi vanotsvaga mhinduro dzakagadzirirwa. Kunyangwe iwe uri kugadzira generic vhezheni kana kugadzira nyowani yemushonga morekuru, tinogona kutsigira timu yako neGlybenzcyclamide Intermediates yakavimbika.
Mutengesi Waunogona Kuvimba
Kwemakore, takavaka hukama hwakasimba nemakambani emishonga muEurope, Asia, uye Americas. Vashandi vedu vepasi rose vanovimba nesu kune:
Pa-nguva yekuendesa, kunyangwe pasi penguva dzakasimba
Mitengo yemakwikwi, pasina kukanganisa pamhando
Kuteerera kutaurirana, nerutsigiro rwakazara rwehunyanzvi uye rwekutonga
Mumwe wevatengi vedu vekuEurope, anogadzira zvinodhaka zvepakati nepakati, akavandudza goho ravo rekugadzira ne18% mushure mekuchinja kune yedu Glybenzcyclamide Intermediates. Izvi zvakashandurirwa mukuchengetedza kwepagore kwepamusoro pe $200,000 uye zvakanyanya kuderedza mishumo yekutsauka kwemitemo.
Isu tinotenda kuti izvi ndizvo zvinoita kudyidzana kwechokwadi: kukura kunoenderana nekuvimba uye kuita.
Kuita Kugadzira Kwenyika Ine Hutano
Sekambani yemishonga, tinonzwisisa mutoro wedu kune vese varwere uye nepasi. Nzvimbo dzedu dzekugadzira dzinoenderana neGMP, ISO9001, uye REACH zviyero. Pamusoro pezvo, isu tinobatikana mune yakasvibira chemistry zvirongwa, tichivavarira kuderedza marara uye kukanganisa kwezvakatipoteredza padanho rega rega rekuita kwedu.
Maitiro edu ehunhu anovimbisa kuti batch yega yega yeGlybenzcyclamide Intermediates inogadzirwa zvakachengeteka, zviri pamutemo, uye zvakachengetedzeka.
Shanda Nesu
Isu kuJiangsu Jingye Pharmaceutical Co., Ltd. hatingori mutengesi weGlybenzcyclamide Intermediates. Isu tiri shamwari yako yezano mukugadzira mishonga yakachengeteka, inoshanda zvakanyanya. Kubva pakuchena kwepamusoro kusvika kukupa kwakavimbika uye kutevedzera mutemo, tinoendesa mhando yaunotarisira-uye sevhisi yaunokodzera.
Shanyira webhusaiti yekambani yedu kuti udzidze zvakawanda nezve zvatiri, kana kuongorora chigadzirwa chedu chakaratidzwa, 4-(2-aminoethyl)benzenesulfonamide, kuti uone kuti tingatsigire sei kugadzirwa kwako kunotevera.
Ngativakei ramangwana rekuvandudzwa kwemishonga — pamwe chete.
Nguva yekutumira: May-06-2025